CB12 white mouthwash

CB12 is a professional-grade oral care brand renowned for its scientifically-backed formula designed to combat halitosis. The brand's origin is tied to research conducted at the University of Oslo's Faculty of Dentistry in Norway, although it was formally commercialized as a Swedish brand. Its unique combination of zinc acetate and chlorhexidine is patented and specifically targets the volatile sulfur compounds (VSCs) that cause bad breath, rather than simply masking them.

The brand was historically owned by the Swedish pharmaceutical company Meda AB. In 2016, Meda was acquired by the American pharmaceutical giant Mylan, which subsequently merged with Upjohn (a division of Pfizer) in 2020 to form Viatris Inc. Consequently, Viatris is the current ultimate owner of the CB12 brand. Manufacturing typically occurs in various locations across Europe and North America where Viatris or its contract manufacturers operate facilities.